InnoCan Pharma Corporation (IP40)
XDUS
Closed
Aug 24, 2026
Day's Range
1.3352 wk Range
0.1220Overview - IP40 - InnoCan Pharma Corporation
Key Statistics
Valuation
P/E (Trailing)
‪-5.40‬
PEG Ratio
‪-0.07‬
Price / Book
‪0.76‬
Profitability
Gross Margin
‪91.10%‬
Profit Margin
‪89.92%‬
Operating Margin
‪0.33%‬
Return on Assets
‪-10.68%‬
Return on Equity
‪-13.64%‬
Ownership
Shares Outstanding
4.49M
Price stats
50-Day Avg
‪1.62‬
200-Day Avg
‪3.64‬
Peers - IP40 - InnoCan Pharma Corporation
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on XDUS.
- IP40XDUSInnoCan Pharma Corporation+90.63%52-week change-5.40P/E (Trailing)‪89.92%‬Profit Margin
- PA8XDUSPaion AG+79.83%52-week change-0.74P/E (Trailing)‪94.10%‬Profit Margin
- 6CWXDUSCharlottes Web Holdings Inc.+74.64%52-week change-1.32P/E (Trailing)‪43.48%‬Profit Margin
- 20MPXDUSMountain Valley MD Holdings Inc.+68.45%52-week change-3.55P/E (Trailing)—Profit Margin
- HLSXDUSAIC Mines Limited+63.90%52-week change—P/E (Trailing)—Profit Margin
- 4KF0XDUSGlass House Brands Inc.+53.83%52-week change-14.00P/E (Trailing)‪42.28%‬Profit Margin
- E7PXDUSIndivior Pharmaceuticals, Inc.+53.57%52-week change18.33P/E (Trailing)‪80.14%‬Profit Margin
Profile Summary - IP40 - InnoCan Pharma Corporation
About
InnoCan Pharma Corporation is a pharmaceutical technology company founded in 2018 and headquartered in Calgary, Canada. It specializes in innovative drug delivery platforms that combine cannabidiol (CBD) with other pharmaceutical ingredients to treat chronic pain, epilepsy, and other medical conditions. Its…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
